Making Medicines Affordable

Home
About GBMA
Advocacy
Generics
Biosimilars
- GBMA Position on Biosimilars
- Key Figures on Biosimilars
Topics
News
- News 2020
- News 2019
- News 2018
- News 2017
- News 2016
- News 2015
- News 2014
GBMA Education
COVID-19 Virus
- COVID-19 Virus: The Facts

You are here: Home / COVID-19 Virus

COVID-19 Virus

Our Members

Juno

Sandoz logo

Mylan

Arrow logo

apotex

Celltrion Healthcare

Fresnius Kabi

generic_partners

southern_cross

commercial_eyes

iqvia

sinapse

Generic Medicines: The Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

The promise of Biosimilars

https://youtu.be/sBDur7xa084 Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and … More…

Medicines Australia and the Generic & Biosimilar Medicines Association granted interim authorisation by the ACCC

April 4, 2020

3 April 2020 Canberra, ACT In an important collaborative step, Medicines Australia (MA) and the Generic and Biosimilar Medicines … More...

The supply of vital medicines is our priority

March 6, 2020

6 March 2020 Canberra, ACT Canberra: Australia’s peak body for generic and biosimilar … More...

GBMA welcomes Fresenius Kabi Australia

October 4, 2019

4 October 2019 Canberra, ACT Canberra: Australia’s peak body representing generic and … More…